v3.25.2
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
REVENUES $ 3,437,727 $ 4,595,531
COST OF REVENUES 3,047,069 3,051,541
GROSS PROFIT 390,658 1,543,990
OPERATING EXPENSES    
Selling expenses 1,021,999 218,375
General and administrative expenses 1,481,255 485,037
Research and development expenses 462,062 512,597
Total operating expenses 2,965,315 1,216,009
(LOSS) INCOME FROM OPERATIONS (2,574,658) 327,981
OTHER INCOME (EXPENSE)    
Interest expense (56,056) (267,948)
Other expenses (15) 0
Total other expenses (56,070) (267,948)
INCOME BEFORE TAXES (2,630,729) 60,033
Income tax expense 0 0
NET (LOSS) INCOME (2,630,729) 60,035
Other comprehensive (loss) income :    
Foreign currency translation adjustment (204,395) 69,702
Total comprehensive income $ (2,835,124) $ 129,735
Basic loss per share $ (0.0276) $ 0.0065
Diluted loss per share $ (0.0276) $ 0.0065
Weighted average number of shares of common stock outstanding – basic [1] 95,464,000 20,000,000
Weighted average number of shares of common stock outstanding –diluted [1] 95,464,000 20,000,000
[1] Retrospectively restated for the effect of 2-for-1 reverse stock split. (Note 16)